Categories
Zydus Lifesciences Limited — Updates, 13-05-2026: General Updates
13-05-2026 · 08:59 pm
Zydus's subsidiary is acquiring US-based Assertio Holdings for ~₹1381 Cr cash. This strategic move fortifies Zydus's US specialty oncology presence, leveraging Assertio's ROLVEDON® product and commercial platform to expand its portfolio.
No comments yet. Be the first to comment!